Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy

• Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE. • Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce. • Higher scores in HADS are associated with lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteagudo-Gimeno, E., Sánchez-González, R., Raduà-Castaño, J., Fortea-González, L., Boget-Llucià, T., Carreño-Martínez, M., Donaire-Pedraza, A., Bargalló-Alabart, N., Setoain-Perego, X., Rumià-Arboix, J., Bulbena-Vilarrasa, A., Pintor-Pérez, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597766/
https://www.ncbi.nlm.nih.gov/pubmed/37886767
http://dx.doi.org/10.1016/j.heliyon.2023.e20903
Descripción
Sumario:• Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE. • Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce. • Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE. • A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist. • There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.

Ejemplares similares